BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, February 17, 2025
See today's BioWorld
Home
» Regulatory actions for Nov. 1, 2021
To read the full article
sign up for free
or
sign in
.
Regulatory actions for Nov. 1, 2021
Nov. 1, 2021
No Comments
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Abbvie, ANI, Antengene, Bionomics, Biontech, Cocrystal, Coherus, Gannex, Hyloris, Incyte, Immutep, Junshi, Medac, Medexus, Moderna, Novartis, Novavax, Orphazyme, Pfizer, Sesen, Sio Gene, Sorrento, Synthekine, Theseus.
BioWorld
Briefs
Regulatory
Regulatory actions
Coronavirus